Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Universal Ibogaine Inc ( (TSE:IBO) ) just unveiled an announcement.
Universal Ibogaine Inc. announced the resignation of Greg Leavens as Chief Financial Officer and Corporate Secretary, as he pursues other opportunities. The company expressed gratitude for his contributions and noted that he will assist in a consulting role during the transition. This change comes as UI continues its mission to revolutionize addiction treatment, potentially impacting its operational dynamics and stakeholder interests.
More about Universal Ibogaine Inc
Universal Ibogaine Inc. is a life sciences company focused on transforming addiction treatment through medicalized ibogaine. The company is planning a Canadian clinical trial targeting opioid use disorder and aims to expand its treatment protocol globally through future licensing agreements. Additionally, UI is developing a holistic addiction treatment protocol at its Kelburn Recovery Centre in Manitoba.
Average Trading Volume: 162,468
Technical Sentiment Signal: Sell
Current Market Cap: C$6.87M
For detailed information about IBO stock, go to TipRanks’ Stock Analysis page.